glucose-dependent insulinotropic peptide (GIP)

glucose-dependent insulinotropic peptide · University Hospital, Gentofte

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for glucose-dependent insulinotropic peptide (GIP), covering 2015-07-14 to 2018-05-25. Get the full timeline:

Most recent: Clinical Trial Update: The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion [Phase 1]